177 related articles for article (PubMed ID: 3143051)
1. Drugs for parkinsonism.
Med Lett Drugs Ther; 1988 Dec; 30(781):113-6. PubMed ID: 3143051
[No Abstract] [Full Text] [Related]
2. Drugs for parkinsonism.
Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639
[No Abstract] [Full Text] [Related]
3. Drugs for parkinsonism.
Med Lett Drugs Ther; 1979 May; 21(9):37-8. PubMed ID: 449844
[No Abstract] [Full Text] [Related]
4. Update on drug treatment of Parkinsonism.
Winkelman AC
Am Fam Physician; 1977 Jul; 16(1):118-20. PubMed ID: 18001
[No Abstract] [Full Text] [Related]
5. Pharmacotherapy: problems and practices.
Muenter MD
Clin Neuropharmacol; 1986; 9 Suppl 1():S23-36. PubMed ID: 3708606
[TBL] [Abstract][Full Text] [Related]
6. Update on the treatment of Parkinson's disease.
Wirz D
Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903
[No Abstract] [Full Text] [Related]
7. Therapy of neurologic disorders in the elderly.
Mancall EL; Covington TR; Alonso RJ
Hosp Pract (Off Ed); 1984 Oct; 19(10):106E, 106I, 106L passim. PubMed ID: 6434551
[No Abstract] [Full Text] [Related]
8. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
Savery F
Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
[No Abstract] [Full Text] [Related]
9. [Drug therapy of parkinsonism].
Teräväinen H; Larsen TA
Duodecim; 1982; 98(11):892-900. PubMed ID: 6125373
[No Abstract] [Full Text] [Related]
10. Drugs for Parkinson's disease.
Med Lett Drugs Ther; 1993 Apr; 35(894):31-4. PubMed ID: 8096322
[No Abstract] [Full Text] [Related]
11. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
Libman I; Gawel MJ; Riopelle RJ; Bouchard S
Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Gawel M; Riopelle R; Libman I; Bouchard S
Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
[No Abstract] [Full Text] [Related]
13. Treating the progressive stages of Parkinson's disease.
Varon J; Jacobs MB
Postgrad Med; 1991 Jul; 90(1):63-6, 69-71. PubMed ID: 1905807
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategies and tactics in parkinsonism].
Birkmayer W
Wien Med Wochenschr; 1986 Aug; 136(15-16):408-11. PubMed ID: 3097964
[TBL] [Abstract][Full Text] [Related]
15. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias.
Mark MH; Sage JI
Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565
[TBL] [Abstract][Full Text] [Related]
16. Milestones in the development of modern Parkinson therapy.
Birkmayer W
J Neural Transm Suppl; 1987; 25():1-3. PubMed ID: 3123596
[No Abstract] [Full Text] [Related]
17. Parkinson's disease.
Lieberman AN
Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
[No Abstract] [Full Text] [Related]
18. Current and future approaches to therapy.
Birkmayer W; Birkmayer JD
Adv Neurol; 1987; 45():511-2. PubMed ID: 3103393
[No Abstract] [Full Text] [Related]
19. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
[TBL] [Abstract][Full Text] [Related]
20. The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Olanow CW; Hauser RA; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
Ann Neurol; 1995 Nov; 38(5):771-7. PubMed ID: 7486869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
